agreed, volume has fallen away at this latest retrace which indicates selling pressure is nearly done. Once profit taking ends, we should see the next leg up.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025